Daraprim (Vyera Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Daraprim drug offered from Vyera Pharmaceuticals LLC. This Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Vyera Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | pyrimethamine |
| SUBSTANCE NAME: | PYRIMETHAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1953-01-23 |
| END MARKETING DATE: | 0000-00-00 |
Daraprim HUMAN PRESCRIPTION DRUG Details:
| Item Description | Daraprim from Vyera Pharmaceuticals LLC |
| LABELER NAME: | Vyera Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 1953-01-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69413-330_38325135-541d-4fc0-bef8-88be76fb3425 |
| PRODUCT NDC: | 69413-330 |
| APPLICATION NUMBER: | NDA008578 |
Other PYRIMETHAMINE Pharmaceutical Manufacturers / Labelers:
